The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
about
Emerging concepts in the immunopathogenesis of AIDSA coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediatorVSIG4, a B7 family-related protein, is a negative regulator of T cell activationBTNL2, a butyrophilin-like molecule that functions to inhibit T cell activationBlockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host diseasePD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitisPhysiological and molecular determinants of embryo implantationPD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity.PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis.LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.B7-1 mediated costimulation regulates pancreatic autoimmunity.Costimulation couture: a designer approach to regulating autoimmunity.Chemotherapy and tumor immunity: an unexpected collaborationCell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways.Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerancePositive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma.The B7/CD28 costimulatory family in autoimmunity.Block and tackle: CTLA4Ig takes on lupus.Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.Immunotherapy for pancreatic cancer - science driving clinical progress.PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccinesTissue expression of PD-L1 mediates peripheral T cell tolerance.Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.A critical role for the programmed death ligand 1 in fetomaternal tolerance.Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cellsRoadmap to a better therapeutic tumor vaccine.Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapyDistinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis.Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaquesSpecial regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation.The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.A Promoter Region Polymorphism in PDCD-1 Gene Is Associated with Risk of Rheumatoid Arthritis in the Han Chinese Population of Southeastern China.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?
P2860
Q22241984-CC3AD0CA-0DF5-4DD9-938B-AE91B0DC5BD7Q24557522-465B507C-89A6-428B-B8C1-C4D2B374F4B9Q28584882-7F8B10BD-1080-4143-A5F9-A6C6162F7248Q28589424-AABA351A-0AE6-4228-AF53-A5CDA99E9304Q33530054-D99C35D4-015C-460C-8762-9DBB09E25824Q34094680-2FBD49CC-6D33-4723-A1C6-4899BBE01469Q34320970-97F899C7-30E8-4A36-8A7E-8E7A397A6F0BQ34556528-E5137E1C-5280-4090-92B3-0E838B8D6CB4Q34570624-3096AC9F-4AA6-47C7-8DC5-48E7EDA0D7C4Q34616332-4D0D3161-699C-4D0F-BD85-C76D426C42C5Q34700552-310AFD8D-4FD2-4E29-86EE-8CE3C02F6030Q34763699-FACD63D9-E25A-445C-9096-F9772DDF9091Q34872786-9EAACB4F-CB2B-4296-BF02-0EA1E3D8AC5DQ34909777-2AC2DA25-7612-4C9E-99AC-0B160A4DF8C2Q35070674-2B1734DB-31E0-4578-A928-6519F4D6DC26Q35563269-BADD6EE2-6856-470B-B803-C4CD3615C6AAQ35749886-D7002084-3E8B-4271-946A-4344946B8DDDQ35760717-4C52C65B-6EE9-41BB-A735-9FA4A87E79E0Q36079881-D9FC00A3-8211-45C1-90AC-58D688BD4BC1Q36088049-929A37FF-0F59-4404-A5CC-B7FAE4705EFBQ36122631-3282C19F-B293-4C62-9540-D2F500C4C05BQ36133140-92494497-8728-403B-99E2-AF6585F48A38Q36220691-CFC2EE50-95EC-40B2-8089-B5686B608FECQ36228541-5A669A18-873C-4C43-825B-B61C0452D9C9Q36349567-D5099588-E8C3-4031-ADA0-81060F4A1E21Q36360561-1CF9C6FA-DB27-4366-98AD-6AB1322D996AQ36403162-1376F62A-F3A4-4576-AD8B-452DE9E6457BQ36562341-EAB0A6F6-8B60-44D6-8175-20CA3CFE9CA6Q36667235-691057E5-C590-4EC5-9194-445843B2D5F1Q36684496-8797ED44-2C1C-4A76-83CF-B21927AB4145Q36692284-97EAA709-2354-4A57-8C4C-16F8A67AD9B8Q36778241-16D60BBB-B707-4486-8F59-923FB0A16574Q37000791-A1CC002D-EE3B-460B-B117-2282C5A6D553Q37043735-1F56D5B1-7DFD-45D6-B41C-C35D441BE527Q37276576-413C9FDC-1310-44A1-9D49-4F8D18EA2C86Q37316915-81EB4BD2-19AC-4A4C-84B4-54EF34EB5AF7Q37501812-C56683BA-76F4-4A7D-BD15-FB2931D90491Q37645635-0A93AB11-5230-469A-9D8A-C364C2949838Q37717899-97ACB4AD-3971-4A01-92C4-3630E24F7652Q37952804-19E106B5-A4A8-4372-AE8E-651BFDD2FC5E
P2860
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@ast
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@en
type
label
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@ast
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@en
prefLabel
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@ast
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@en
P1433
P1476
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.
@en
P2093
Mohamed H Sayegh
P304
P356
10.1016/S1074-7613(04)00116-5
P407
P50
P577
2004-05-01T00:00:00Z